PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
799.80%
Cash & equivalents growing 799.80% while RVPH's declined -100.00%. Peter Lynch would see this as a sign of superior liquidity management.
No Data
No Data available this quarter, please select a different quarter.
799.80%
Below half of RVPH's 20084.63%. Michael Burry might suspect a liquidity shortfall if there's no alternative capital plan.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
700.88%
Below half of RVPH's 20084.63%. Michael Burry could suspect a liquidity squeeze. Verify operational performance.
-9.67%
Below half RVPH's -100.00%. Michael Burry sees potential underinvestment risk unless there's a valid reason (asset-light model).
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-6.93%
Below half of RVPH's -100.00%. Michael Burry might suspect stagnation or lack of resources for expansions.
No Data
No Data available this quarter, please select a different quarter.
569.03%
Below half of RVPH's 17289.84%. Michael Burry sees a potential red flag for stagnation or capital shortage.
1.26%
Less than half of RVPH's -100.00%. David Dodd sees a more disciplined AP approach or lower volume.
-42.54%
Less than half of RVPH's -100.00%. David Dodd sees much smaller short-term leverage burden vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
5.04%
Higher Deferred Revenue (Current) Growth compared to RVPH's zero value, indicating better performance.
No Data
No Data available this quarter, please select a different quarter.
-1.15%
Less than half of RVPH's -100.00%. David Dodd sees a more disciplined short-term liability approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-16.72%
Higher Total Non-Current Liabilities Growth compared to RVPH's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
-2.99%
Less than half of RVPH's -100.00%. David Dodd sees far fewer liability expansions relative to competitor.
-92.57%
Similar yoy changes to RVPH's -100.00%. Walter Schloss sees parallel capital-raising strategies.
-2.16%
Below half RVPH's 100.00%. Michael Burry suspects major net losses or high dividends vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1581.26%
Below half RVPH's -100.00%. Michael Burry sees potential underperformance in building shareholder capital.
569.03%
Below half RVPH's 17289.84%. Michael Burry sees significant shrinkage or inactivity vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
-16.19%
Less than half of RVPH's -100.00%. David Dodd sees less overall debt expansion vs. competitor.
-1028.99%
Above 1.5x RVPH's -100.00%. Michael Burry sees a major gap in net debt growth. Check coverage and liquidity.